No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma.
No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma. — المؤلف: Saeki, Issei — Liver cancer Oct 2018
- المؤلف
- Saeki, Issei
- النشر
- Liver cancer Oct 2018
- الوصف
- 359-371 p.